Bioinvent International Revenue and Competitors
Estimated Revenue & Valuation
- Bioinvent International's estimated annual revenue is currently $24.6M per year.
- Bioinvent International's estimated revenue per employee is $155,000
Employee Data
- Bioinvent International has 159 Employees.
- Bioinvent International grew their employee count by 6% last year.
Bioinvent International's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Clinical Developement | Reveal Email/Phone |
2 | VP Preclinical | Reveal Email/Phone |
3 | Immunology Director | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Director at BioInvent Manufacturing | Reveal Email/Phone |
6 | Director QA | Reveal Email/Phone |
7 | CMC Project Director, Head CMC Project Management | Reveal Email/Phone |
8 | Senior Director Investor Relations | Reveal Email/Phone |
9 | QC Director | Reveal Email/Phone |
10 | Chief Business Officer | Reveal Email/Phone |
Bioinvent International Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Bioinvent International?
BioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapies, with four programs in clinical development. The Company's validated, proprietary F.I.R.S.Tâ„¢ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.
keywords:N/A
N/A
Total Funding
159
Number of Employees
$24.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bioinvent International News
Lund, Sweden April 28, 2022 BioInvent International AB (BioInvent) (Nasdaq Stockholm: BINV), a biotech company focused on the...
BioInvent International press release (OTC:BOVNF): Q1 GAAP EPS of -SEK 1.16. Revenue of SEK 16.7M (+169.4% Y/Y). Cash flow from operating...
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class...
Other Companies in Lund
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $31.5M | 159 | 31% | N/A |
#2 | $35M | 195 | 3% | N/A |
#3 | $32.1M | 207 | 2% | N/A |
#4 | $34.3M | 215 | N/A | N/A |
#5 | $35M | 241 | -19% | N/A |